| Monotherapy (%) | Combination (%) | P |
---|---|---|---|
Overall treatment failure | 24/49(49) | 14/56(25) | 0.01 |
Source: | Â | Â | Â |
Blood | 12/24 (50) | 9/32(28) | 0.09 |
Pulmonary | 10/15(67) | 5/17(29) | 0.03 |
Urine | 1/8(13) | 0/3(0) | 0.4 |
Polymyxin treatment failure | 8/11(73) | 10/34(29) | 0.02 |
Carbapenem treatment failure | 12/20(60) | 5/19(26) | 0.03 |
Tigecycline treatment failure | 2/7(29) | 7/19(37) | 0.4 |
Aminoglycoside treatment failure | 0/6(0) | 4/24(17) | 0.6 |